# reload+after+2024-01-22 08:46:50.944703
address1§42127 Pleasant Forest Court
city§Ashburn
state§VA
zip§20148-7349
country§United States
phone§703 980 4182
website§https://quoinpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn, Virginia.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Michael  Myers Ph.D.', 'age': 61, 'title': 'Co-Founder, CEO & Chairman', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 854612, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Denise  Carter', 'age': 54, 'title': 'Co-Founder, COO & Director', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 783215, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Gordon Bruce Dunn J.D.', 'age': 59, 'title': 'Chief Financial Officer', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 523385, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.246
currency§USD
dateShortInterest§1702598400
forwardEps§-6.87
exchange§NCM
quoteType§EQUITY
shortName§Quoin Pharmaceuticals, Ltd.
longName§Quoin Pharmaceuticals, Ltd.
firstTradeDateEpochUtc§1470058200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§32cb2815-c927-3d74-8136-d444e5765139
gmtOffSetMilliseconds§-18000000
targetHighPrice§240.0
targetLowPrice§6.94
targetMeanPrice§87.31
targetMedianPrice§15.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§3
quickRatio§3.052
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
